Habilis Biotech Innovations Limited
05414904
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
- 1 outstanding charge (-2)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 01/04/2023
MANAGING DIRECTOR
BRITISH · UNITED KINGDOM · Age 46
Also on 1 other board
Persons with Significant Control
Helena Laboratories (U.K.) Limited
Unit B, M361, Queensway South, Gateshead, NE11 0SD
Reg: 01796207 · England · Private Limited Company
Notified 01/04/2023
Former PSCs
Dr Marc Lamplugh
Ceased 01/04/2023
Charges1 outstanding
THE ROYAL BANK OF SCOTLAND PLC
CompanyRankvs 268+ SIC 72190 peers74
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2022
Net Worth
£143k
Balance sheet strength
Cash
£71k
Cash in the bank
Net Current Assets
£155k
Working capital
Current Assets
£194k
Current Liabilities
£38k
Fixed Assets
£4k
Debtors
£114k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2022 | 5.06 | -£3k |
| 2021 | 3.71 | +£513 |
| 2020 | 5.16 | — |
Derived from filed accounts. Not audited figures.